A new study in a collaboration with researchers from Denmark, Finland, Iceland, Norway, and Sweden, investigates the use of opioids for pain with registers of filled prescriptions maintained in all five countries.
News - Page 2
Professor Thomas Clausen has written a commentary in the journal Addiction on overdose prevention in light of the American opioid crisis.
In a new study SERAF researchers take a look at staff preferences for electronic data collection in the Norwegian take-home naloxone program.
A new article from SERAF and the Department of Forensic Sciences (Oslo University Hospital) shows that painkillers such as oxycodone, tramadol and codeine now dominate as a cause of fatal overdoses.
The 13th LAR Conference was held in downtown Oslo on October 20th and 21st, 2022
SERAF, Oslo University Hospital, and Innlandet Hospital Trust researchers have recently published an article in Addiction on death among OAT patients in Norway.
Researchers at OUS and SERAF have recently published an article on opioid treatment and follow-up after hospital discharge for patients following a serious accident and surgery at Norway's largest trauma center.
Researchers at Oslo University Hospital, SERAF and the Karolinska Institute have recently published an article on physical exercise as a part of drug treatment.
In a large cohort study, SERAF's Svetlana Skurtveit and others find a high prevalence of psychoactive drug use among trauma patients.
SERAF researcher Svetlana Skurtveit has contributed to the publication of a national cohort study of opioid prescriptions for cancer patients.
SERAF recently published the 2020 annual status report for opioid maintenance treatment (OMT).
Many inmates in Norwegian prisons are guilty of offenses that indicate drug use.
SERAF researchers have collaborated with colleagues in Denmark on a recently published article in Drug and Alcohol Dependence.
In a new article, SERAF researchers Desiree Eide and Thomas Clausen, in collaboration with King's College, suggest improvements to research methods regarding "take home" naloxone (THN).
In Norway naloxone nasal spray is distributed under the auspices of SERAF on behalf of the Norwegian Directorate of Health as part of a national overdose strategy (Nalokson.org). Naloxone nasal spray is an antidote treatment for opioid overdose.
In a recently published article, researchers at SERAF and NIPH together with the user organization proLAR-Nett, have investigated the somatic disease burden for aging long-term patients in OMT.
Researchers at SERAF and partners have recently published an article on COVID-19 among drug users in the downtown environments of Oslo, Bergen and Kristiansand.
The Norwegian government has decided to introduce heroin assisted treatment (HAT) as part of opioid maintenance treatment (OMT), as a trial project in Oslo and Bergen, with a 5 year duration.
A recent paper on Covid-19 and the treatment of substance use disorders with a focus on opioid agonist treatment, published by a large international group with contributions also from SERAF.
The Coronavirus is now spreading in most populations worldwide. Persons with SUD, both in and out of treatment, must be considered as extra vulnerable groups in this context.
The effect of opioid maintenance treatment (OMT) on overdose mortality varies both between and within countries. Consequently, treatment programs need to be evaluated in different treatment settings and over time within settings.
Treatment for a substance use disorder can be challenging, whether residential or outpatient. Having a social network that provides emotional and functional support and that specifically supports abstinence can be vital to staying in treatment.
The Norwegian Offender Mental Health and Addiction Study (NORMA), led by Anne Bukten of SERAF/OUS, is one of the largest surveys in the world.
.jpg?alt=listing)
The North American opioid epidemic began with over-prescription of the powerful pain medication oxycodone for chronic non-cancer pain.
The NORMA research group at SERAF (Norwegian Offender Mental Health and Addiction Study) looked at how prisoners changed various health-related behaviors during incarceration, in the absence of specific interventions.
In a recent ambulance study, 1054 non-fatal opioid overdoses in central Oslo were examined to understand if opening hours at a safe injection facility affected these overdoses, and what role the overdose location may have on severity and ambulance transport.